Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Illumina Partners With Allelica, Inc.

By: 3BL Media

Partnership aims to provide better understanding of common disease risk prediction through their Polygenic Risk Score (PRS) software suite

SOURCE: Illumina

DESCRIPTION:

By Susan Tousi
Chief Commercial Officer at Illumina

Customers and our partners represent the heartbeat of Illumina. They help us advance our mission to improve human health through unlocking the power of the genome.

And as we enter further into the era of genomic medicine, personalized medicine must play a more integral role for every patient’s health.

That’s why I am especially thrilled to announce our new partnership with Allelica, Inc, a pioneering biotech firm that provides a cutting-edge approach for better understanding common disease risk prediction through their Polygenic Risk Score (PRS) software suite.

In the future, enabling PRS testing for individuals who have a high genetic probability of life-threatening diseases can increase the likelihood of early intervention and therefore save lives. The new partnership with Allelica, Inc will enable Illumina to provide the world’s first holistic PRS enablement solution on the market, and as a result, provide our customers with a broad range of tools through our connected analytics ecosystem.

Illumina's partnership with Allelica, Inc will enable the translational research community to help mature the field and utility of polygenic risk scores, to eventually transform disease understanding and prevention in common diseases including coronary artery disease, colon cancer, Alzheimer's, and others. I am proud that both Illumina and Allelica, Inc are expanding access to a powerful PRS toolkit to empower the development of a precision care future.

Our collaboration means our customers can utilize tomorrow's genomic risk prediction tools, today.

Learn more about Illumina here

Learn more about Allelica, Inc. here

Tweet me: .@illumina has partnered with @Allelica_PRS. The partnership will empower researchers to mature the field of #polygenic risk score (PRS) and help transform the way we think about human health. Learn more here: https://bit.ly/3FdOEBW #Genomics

KEYWORDS: NASDAQ: ILMN, illumina, Allelica, Polygenic Risk Score, genomic medicine

Allelica: The polygenic risk score company; logo.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.